| Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7 WA He, F Calore, P Londhe, A Canella, DC Guttridge, CM Croce Proceedings of the National Academy of Sciences 111 (12), 4525-4529, 2014 | 252 | 2014 |
| HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity R Gavioli, E Gallerani, C Fortini, M Fabris, A Bottoni, A Canella, ... The Journal of Immunology 173 (6), 3838-3843, 2004 | 129 | 2004 |
| Effect of interferon‐α therapy on epitope‐specific cytotoxic T lymphocyte responses in hepatitis C virus‐infected individuals S Vertuani, M Bazzaro, G Gualandi, F Micheletti, M Marastoni, C Fortini, ... European journal of immunology 32 (1), 144-154, 2002 | 103 | 2002 |
| Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers SW Harshman, A Canella, PD Ciarlariello, K Agarwal, OE Branson, ... Journal of proteomics 136, 89-98, 2016 | 85 | 2016 |
| Biologically active platinum complexes containing 8-thiotheophylline and 8-(methylthio) theophylline A Romerosa, P Bergamini, V Bertolasi, A Canella, M Cattabriga, R Gavioli, ... Inorganic Chemistry 43 (3), 905-913, 2004 | 79 | 2004 |
| The Toll‐like receptor ligand MALP‐2 stimulates dendritic cell maturation and modulates proteasome composition and activity C Link, R Gavioli, T Ebensen, A Canella, E Reinhard, CA Guzman European journal of immunology 34 (3), 899-907, 2004 | 78 | 2004 |
| Hybrid α-bromoacryloylamido chalcones. Design, synthesis and biological evaluation R Romagnoli, PG Baraldi, MD Carrion, O Cruz-Lopez, CL Cara, ... Bioorganic & Medicinal Chemistry Letters 19 (7), 2022-2028, 2009 | 72 | 2009 |
| Efficacy of onalespib, a long-acting second-generation HSP90 inhibitor, as a single agent and in combination with temozolomide against malignant gliomas A Canella, AM Welker, JY Yoo, J Xu, FS Abas, D Kesanakurti, ... Clinical Cancer Research 23 (20), 6215-6226, 2017 | 69 | 2017 |
| Phosphinic platinum complexes with 8-thiotheophylline derivatives: synthesis, characterization, and antiproliferative activity P Bergamini, V Bertolasi, L Marvelli, A Canella, R Gavioli, N Mantovani, ... Inorganic chemistry 46 (10), 4267-4276, 2007 | 68 | 2007 |
| A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T-and B-cell lymphomas DW Sborov, A Canella, EM Hade, X Mo, S Khountham, J Wang, W Ni, ... Leukemia & lymphoma 58 (10), 2310-2318, 2017 | 51 | 2017 |
| Characterization of multiple myeloma vesicles by label‐free relative quantitation SW Harshman, A Canella, PD Ciarlariello, A Rocci, K Agarwal, EM Smith, ... Proteomics 13 (20), 3013-3029, 2013 | 50 | 2013 |
| HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide A Canella, HC Nieves, DW Sborov, L Cascione, HS Radomska, E Smith, ... Oncotarget 6 (31), 31134, 2015 | 49 | 2015 |
| Production of β‐globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients F Salvatori, G Breveglieri, C Zuccato, A Finotti, N Bianchi, M Borgatti, ... American journal of hematology 84 (11), 720-728, 2009 | 46 | 2009 |
| Mesenchymal stem cells from patients to assay bone graft substitutes M Manfrini, C Di Bona, A Canella, E Lucarelli, A Pellati, A D'Agostino, ... Journal of Cellular Physiology 228 (6), 1229-1237, 2013 | 45 | 2013 |
| Histone deacetylase inhibitors enhance the therapeutic potential of reovirus in multiple myeloma A Stiff, E Caserta, DW Sborov, GJ Nuovo, X Mo, SY Schlotter, A Canella, ... Molecular cancer therapeutics 15 (5), 830-841, 2016 | 41 | 2016 |
| Influence of obstetric factors on osteogenic potential of umbilical cord-derived mesenchymal stem cells L Penolazzi, R Vecchiatini, S Bignardi, E Lambertini, E Torreggiani, ... Reproductive Biology and Endocrinology 7, 1-7, 2009 | 40 | 2009 |
| Water-soluble Cp ruthenium complex containing 1, 3, 5-triaza-7-phosphaadamantane and 8-thiotheophylline derivatives: synthesis, characterization, and antiproliferative activity L Hajji, C Saraiba-Bello, A Romerosa, G Segovia-Torrente, ... Inorganic Chemistry 50 (3), 873-882, 2011 | 38 | 2011 |
| The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T‐lymphocyte responses MICHELETTI, BAZZARO, CANELLA, MARASTONI, TRANIELLO, GAVIOLI Immunology 96 (3), 411-415, 1999 | 37 | 1999 |
| Single-cell RNA sequencing reveals immunosuppressive myeloid cell diversity during malignant progression in a murine model of glioma S Rajendran, Y Hu, A Canella, C Peterson, A Gross, M Cam, M Nazzaro, ... Cell reports 42 (3), 2023 | 33 | 2023 |
| Arecoline tripeptide inhibitors of proteasome M Marastoni, A Baldisserotto, A Canella, R Gavioli, CD Risi, GP Pollini, ... Journal of medicinal chemistry 47 (6), 1587-1590, 2004 | 33 | 2004 |
